ABL Bio's chart data is dated 2026-10-08. Recorded technical signals: MACD bullish cross. There are 0 published signal records.
ABL Bio last closed at ₩48,150 (-5.77%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSDAQ. Trailing 12 months PER is -34.2×. Its overall grade ranks 289 of 308 stocks in Healthcare.
About this company
ABL Bio last closed at ₩48,150 (-5.77%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall F · 289/308
Valuation grade B
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 사노피Customer
ABL301 등 공동개발·기술이전 관련 주요 파트너
- 컴퍼스 테라퓨틱스Customer
이중항체 파이프라인 기술이전·공동개발 연관
- GSKCustomer
ABL502 등 면역항암/이중항체 협력 가능성이 큰 글로벌 파트너
ETFs holding this stock
HANARO 바이오코리아액티브 · KoAct 바이오헬스케어액티브 · TIGER 코스닥150바이오테크
Details →About ABL Bio
- What technical signals does ABL Bio (298380) have?
- ABL Bio current technical signals: MACD bullish cross.
- Is ABL Bio a cup-and-handle pattern?
- No. ABL Bio has no valid Cup signal right now.
- What published figures are available for ABL Bio?
- Market cap: KRW 2.6T. Trailing 12 months PER: -34.2×. Latest quarter PBR: 15.67×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about ABL Bio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.